SUNITINIB MALATE AS A SINGLE AGENT OR COMBINED WITH LOMUSTINE (CCNU) IN PATIENTS WITH RECURRENT, TEMOZOLOMIDE REFRACTORY HIGH-GRADE GLIOMA

被引：0
|
作者：
Neyns, B. [1 ]
Lv, S. [1 ]
Chaskis, C. [2 ]
Sadones, J. [1 ]
Dujardin, M. [1 ]
Everaert, H. [1 ]
Duerinck, J. [1 ]
Nupponen, N. [3 ]
Michotte, A. [1 ]
De Greve, J. [1 ]
机构：
[1] UZ Brussel, Brussels, Belgium
[2] CHU Charleroi, Charleroi, Belgium
[3] Univ Helsinki, Helsinki, Finland
来源：
NEURO-ONCOLOGY | 2010年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：16 / 16
页数：1
相关论文
共 50 条
  • [1] Phase II trial of sunitinib malate in patients with temozolomide refractory recurrent high-grade glioma
    Neyns, B.
    Chaskis, C.
    Dujardin, M.
    Everaert, H.
    Sadones, J.
    Nupponen, N. N.
    Michotte, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [2] Sunitinib Malate plus Lomustine for Patients with Temozolomide-refractory Recurrent Anaplastic or Low-grade Glioma
    Duerinck, Johnny
    Du Four, Stephanie
    Sander, Wilhelm
    Van Binst, Anne-Marie
    Everaert, Hendrik
    Michotte, Alex
    Hau, Peter
    Neyns, Bart
    [J]. ANTICANCER RESEARCH, 2015, 35 (10) : 5551 - 5557
  • [3] SUNITINIB MALATE IN COMBINATION WITH LOMUSTINE FOR PATIENTS WITH TEMOZOLOMIDE REFRACTORY RECURRENT WHO-GRADE II/III GLIOMAS
    Duerinck, J.
    Du Four, S.
    Van Binst, A.
    Everaert, H.
    Michotte, A.
    D'haens, J.
    Neyns, B.
    [J]. NEURO-ONCOLOGY, 2012, 14 : 43 - 44
  • [4] Temozolomide versus Procarbazine, Lomustine, and Vincristine in Recurrent High-grade Glioma
    Nieder, Carsten
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 (05) : 333 - 335
  • [5] Phase II study of sunitinib malate in patients with recurrent high-grade glioma
    Neyns, B.
    Sadones, J.
    Chaskis, C.
    Dujardin, M.
    Everaert, H.
    Lv, S.
    Duerinck, J.
    Tynninen, O.
    Nupponen, N.
    Michotte, A.
    De Greve, J.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2011, 103 (03) : 491 - 501
  • [6] Phase II study of sunitinib malate in patients with recurrent high-grade glioma
    B. Neyns
    J. Sadones
    C. Chaskis
    M. Dujardin
    H. Everaert
    S. Lv
    J. Duerinck
    O. Tynninen
    N. Nupponen
    A. Michotte
    J. De Greve
    [J]. Journal of Neuro-Oncology, 2011, 103 : 491 - 501
  • [7] Temozolomide Versus Procarbazine, Lomustine, and Vincristine in Recurrent High-Grade Glioma
    Brada, Michael
    Stenning, Sally
    Gabe, Rhian
    Thompson, Lindsay C.
    Levy, David
    Rampling, Roy
    Erridge, Sara
    Saran, Frank
    Gattamaneni, Rao
    Hopkins, Kirsten
    Beall, Sarah
    Collins, V. Peter
    Lee, Siow-Ming
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (30) : 4601 - 4608
  • [8] Phase II trial of sunitinib malate and lomustine in patients with temozolomide refractory recurrent low-grade and anaplastic gliomas.
    Duerinck, Johnny
    Du Four, Stephanie
    Van Binst, An
    Everaert, Hendrik
    Michotte, Alex
    D'haens, Jean
    Neyns, Bart
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [9] Temozolomide for recurrent high-grade glioma
    Macdonald, DR
    [J]. SEMINARS IN ONCOLOGY, 2001, 28 (04) : 3 - 12
  • [10] Temozolomide (TMZ) and lomustine (CCNU) in high grade glioma (HGG) patients: Phase I study.
    Tafuto, S
    Guarrasi, R
    Tortoriello, A
    Buzzi, F
    Muto, P
    Formato, R
    Comella, P
    De Rosa, P
    Iaffaioli, RV
    Quattrin, S
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 126S - 126S
12345